The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M. H., Freemantle, N., Boynton, J. R., Churchill, R. C., Eccles, M., Geddes, J. R., Hardy, R., Lewis, G., & Mason, J. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 87
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Tomlinson, G., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., Radford, K., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07968 · Cited by 797
Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis
Serretti, A., & Mandelli, L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05346blu · Cited by 621
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
Gershon, M. D. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835bc703 · Cited by 617
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
Serretti, A., & Chiesa, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a5233f · Cited by 583
Emergence of intense suicidal preoccupation during fluoxetine treatment
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.207 · Cited by 532
Antidepressant use in persons aged 12 and over: United States, 2005-2008.
Pratt, L. A., Brody, D. J., & Gu, Q. (2011) · PubMed · Cited by 490
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citationRelative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A., & Whyte, I. M. (2004) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 435
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
Wasserman, D., Rihmer, Z., Rujescu, D., Sarchiapone, M., Sokolowski, M., Titelman, D., Zalsman, G., Zemishlany, Z., & Carli, V. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.06.003 · Cited by 390
Weight gain and antidepressants.
D, M. F. M. (2000) · PubMed · Cited by 388
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors
Leo, R. J. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1002 · Cited by 364
Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study
Price, J., Cole, V., & Goodwin, G. M. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051110 · Cited by 362
Chen, M., Borlak, J., & Tong, W. (2013) · Hepatology · doi:10.1002/hep.26208 · Cited by 348
Zimmermann, U., Kraus, T., Himmerich, H., Schuld, A., & Pollmächer, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00018-9 · Cited by 347
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.11.001 · Cited by 345
Adverse Drug Reactions: A Critical Review
Karch, F. E. (1975) · JAMA · doi:10.1001/jama.1975.03260250028021 · Cited by 335
Preskorn, S. (1995) · PubMed · Cited by 326
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Sharma, T., Guski, L. S., Freund, N., & Gøtzsche, P. C. (2016) · BMJ · doi:10.1136/bmj.i65 · Cited by 319
Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv082 · Cited by 315
Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus
Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071065 · Cited by 314
Andrade, C., Sandarsh, S., Chethan, K. B., & Nagesh, K. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05786blu · Cited by 302
Adverse reactions to antidepressants
Uher, R., Farmer, A., Henigsberg, N., Rietschel, M., Mors, O., Maier, W., Kozel, D., Hauser, J., Souery, D., Placentino, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.061960 · Cited by 302
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Antidepressant-Induced Liver Injury: A Review for Clinicians
Voican, C. S., Corruble, E., Naveau, S., & Perlemuter, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13050709 · Cited by 275
Sexual problems in healthy and depressed persons
Angst, J. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199807006-00001 · Cited by 270
Drug-Induced Urinary Retention: Incidence, Management and Prevention
Verhamme, K. M. C., Sturkenboom, M. C. J. M., Stricker, B. H. C., & Bosch, R. (2008) · Drug Safety · doi:10.2165/00002018-200831050-00002 · Cited by 264
Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults
Jacob, S., & Spinier, S. A. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g293 · Cited by 262
Mania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256
Meta-Analysis of Selective Serotonin Reuptake Inhibitor–Associated QTc Prolongation
Beach, S. R., Kostis, W. J., Celano, C. M., Januzzi, J. L., Ruskin, J. N., Noseworthy, P. A., & Huffman, J. C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08672 · Cited by 253
Trindade, E. M., Menon, D., Topfer, L.-A., & Coloma, C. (1998) · Europe PMC (PubMed Central) · Cited by 252
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Self-citationRestless legs syndrome as side effect of second generation antidepressants
Rottach, K. G., Schaner, B. M., Kirch, M. H., Zivotofsky, A. Z., Teufel, L. M., Gallwitz, T., & Messer, T. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.02.006 · Cited by 249
Silverstone, P. H., Ravindran, A., & the Venlafaxine XR 360 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0105 · Cited by 246
Rubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., Haffner, S. M., Price, D. W., Knowler, W. C., & for the Diabetes Prevention Program Research Group (2008) · Diabetes Care · doi:10.2337/dc07-1827 · Cited by 242
Influence of antidepressants on hemostasis
Halperin, D., & Reber, G. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.1/dhalperin · Cited by 242
Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L., & Lohr, K. N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00008 · Cited by 237
Peretti, S., Judge, R., & Hindmarch, I. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2000.tb10944.x · Cited by 236
Anglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.82 · Cited by 234
Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study
Chun-Fai-Chan, B., Koren, G., Fayez, I., Kalra, S., Voyer-Lavigne, S., Boshier, A., Shakir, S., & Einarson, A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.027 · Cited by 234
Fava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1113 · Cited by 229
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
Khoo, A. L., Zhou, H. J., Teng, M., Lin, L., Zhao, Y. J., Soh, L. B., Mok, Y. M., Lim, B. P., & Gwee, K. P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0267-6 · Cited by 228
Citrome, L. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02885.x · Cited by 228
Spigset, O. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00007 · Cited by 225
Neurological complications of psychiatric drugs: clinical features and management
Haddad, P. M., & Dursun, S. M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.918 · Cited by 223
Ocular Adverse Effects of Common Psychotropic Agents: A Review
Richa, S., & Yazbek, J.-C. (2010) · CNS Drugs · doi:10.2165/11533180-000000000-00000 · Cited by 217
Jiang, H.-Y., Chen, H.-Z., Hu, X.-J., Yu, Z.-H., Yang, W., Deng, M., Zhang, Y.-H., & Ruan, B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.06.021 · Cited by 213
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
Brandes, L. J., Arron, R. J., Bogdanovic, R. P., TONG, J. J., Zaborniak, C. L., Hogg, G. R., Warrington, R. C., Fang, W., & LaBella, F. S. (1992) · PubMed · Cited by 211
de Abajo, F. J. (2011) · Drugs & Aging · doi:10.2165/11589340-000000000-00000 · Cited by 206
de Abajo, F. J., & García-Rodríguez, L. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.795 · Cited by 206
Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Tomlinson, G., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., & Ross, L. E. (2014) · BMJ · doi:10.1136/bmj.f6932 · Cited by 197
Antidepressant Medication Use, Weight Gain, and Risk of Type 2 Diabetes
Kivimäki, M., Hamer, M., Batty, G. D., Geddes, J. R., Tabak, A. G., Pentti, J., Virtanen, M., & Vahtera, J. (2010) · Diabetes Care · doi:10.2337/dc10-1187 · Cited by 195
Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose
Hawton, K., Bergen, H., Simkin, S., Cooper, J., Waters, K., Gunnell, D., & Kapur, N. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.070219 · Cited by 192
Kemp, A. H., Brunoni, A. R., Santos, I. S., Nunes, M. A., Dantas, E. M., Carvalho de Figueiredo, R., Pereira, A. C., Ribeiro, A. L. P., Mill, J. G., Andreão, R. V., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121605 · Cited by 189
Self-citationAntidepressants and the Risk of Hyponatremia: A Class-by-Class Review of Literature
De Picker, L., Van Den Eede, F., Dumont, G., Moorkens, G., & Sabbe, B. G. C. (2014) · Psychosomatics · doi:10.1016/j.psym.2014.01.010 · Cited by 186
Furu, K., Kieler, H., Haglund, B., Engeland, A., Selmer, R., Stephansson, O., Valdimarsdottir, U. A., Zoega, H., Artama, M., Gissler, M., et al. (2015) · BMJ · doi:10.1136/bmj.h1798 · Cited by 185
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Roerecke, M., Rehm, J., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07966 · Cited by 181
Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review
Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181
Self-citationGadde, K. M., Parker, C. B., Maner, L. G., Wagner, H. R., Logue, E. J., Drezner, M. K., & Krishnan, K. R. R. (2001) · Obesity Research · doi:10.1038/oby.2001.71 · Cited by 176
New targets for rapid antidepressant action
Machado‐Vieira, R., Henter, I. D., & Zarate, C. A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.001 · Cited by 175
Sexual side-effects of antidepressant and antipsychotic drugs
Montejo, A. L., Montejo, L., & Navarro-Cremades, F. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000198 · Cited by 175
A Comparison of the Risk of QT Prolongation Among SSRIs
Funk, K. A., & Bostwick, J. R. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013501994 · Cited by 174
Goldstein, B. J., & Goodnick, P. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003041 · Cited by 171
Antidepressants and Falls in the Elderly
Darowski, A., Chambers, S.-A. C. F., & Chambers, D. J. (2009) · Drugs & Aging · doi:10.2165/00002512-200926050-00002 · Cited by 171
Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant
Meltzer, H. Y., Young, M., Metz, J., Fang, V. S., Schyve, P. M., & Arora, R. C. (1979) · Journal of Neural Transmission · doi:10.1007/bf01250091 · Cited by 167
Guidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
Self-citationNew Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Reefhuis, J., Devine, O., Friedman, J. M., Louik, C., & Honein, M. A. (2015) · BMJ · doi:10.1136/bmj.h3190 · Cited by 161
Drug-Induced Hyperhidrosis and Hypohidrosis: Incidence, Prevention and Management
Cheshire, W. P., & Fealey, R. D. (2008) · Drug Safety · doi:10.2165/00002018-200831020-00002 · Cited by 161
Depression as a risk factor for osteoporosis
Cizza, G., Primma, S., & Csako, G. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.003 · Cited by 161
Reichenpfader, U., Gartlehner, G., Morgan, L. C., Greenblatt, A., Nussbaumer, B., Hansen, R. A., Van Noord, M., Lux, L., & Gaynes, B. N. (2014) · Drug Safety · doi:10.1007/s40264-013-0129-4 · Cited by 160
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
Self-citationAntidepressants and Sexual Dysfunction: Mechanisms and Clinical Implications
Clayton, A. H., Croft, H. A., & Handiwala, L. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.03.2744 · Cited by 158
Sexual side-effects of antidepressant and antipsychotic drugs
Baldwin, D. S., & Mayers, A. (2003) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.3.202 · Cited by 155
Wu, Q. F., Bencaz, A. F., Hentz, J. G., & Crowell, M. D. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1778-8 · Cited by 151
Gil‐Ad, I., Zolokov, A., Lomnitski, L., Taler, M., Bar, M., Luria, D., Ram, E., & Weizman, A. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000007 · Cited by 149
Depression, heart rate related variables and cardiovascular disease
Taylor, C. B. (2010) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.04.006 · Cited by 148
Is increased antidepressant exposure a contributory factor to the obesity pandemic?
Lee, S. H., Paz-Filho, G., Mastronardi, C. A., Licinio, J., & Wong, M. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.25 · Cited by 148
Ziere, G. J., Dieleman, J. P., van der Cammen, T. J. M., Albert Hofman, D., Pols, H. A. P., & Stricker, B. H. C. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31817e0ecb · Cited by 147
In Quest of Identifying Vulnerability Markers for Psychiatric Disorders by All-Night Polysomnography
Lauer, C. J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950140063009 · Cited by 147
Citrome, L. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12350 · Cited by 147
Anderson, H. D., Pace, W. D., Libby, A. M., West, D. R., & Valuck, R. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.024 · Cited by 147
Use of psychotropic drugs during pregnancy and breast‐feeding
Larsen, E. R., Damkier, P., Pedersen, L. H., Fenger‐Grøn, J., Mikkelsen, R. L., Nielsen, R. E., Linde, V., Knudsen, H. E. D., Skaarup, L., & Videbech, P. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12479 · Cited by 145
Cardiovascular safety in depressed patients: focus on venlafaxine.
Feighner, J. P. (1995) · PubMed · Cited by 143
Palmsten, K. K., Hernández–Díaz, S., Huybrechts, K. F., Williams, P. L., Michels, K. B., Achtyes, E. D., Mogun, H., & Setoguchi, S. (2013) · BMJ · doi:10.1136/bmj.f4877 · Cited by 142
Einarson, A., Bonari, L., Lavigne, S. V., Addis, A., Matsui, D. M., Johnson, Y., & Koren, G. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800207 · Cited by 139
Exposure to Mirtazapine During Pregnancy
Djulus, J., Koren, G., Einarson, T. R., Wilton, L., Shakir, S., Diav‐Citrin, O., Kennedy, D. A., Lavigne, S. V., Santis, M. D., & Einarson, A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0817 · Cited by 138
Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology
Browning, K. N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00413 · Cited by 138
Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors
Moret, C., Isaac, M., & Briley, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093582 · Cited by 135
Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
Clayton, A. H., Haddad, S. E., Iluonakhamhe, J.-P., Martinez, C. C. P., & Schuck, A. E. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.951324 · Cited by 134
Sleep Changes After 4 Consecutive Days of Venlafaxine Administration in Normal Volunteers
Salín-Pascual, R. J., Galicia-Polo, L., & Drucker-Colı́n, R. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0803 · Cited by 132
Psychotropic-Induced Hyperprolactinemia: A Clinical Review
Ajmal, A., Joffe, H., & Nachtigall, L. B. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.08.008 · Cited by 131
Thor, K. B. (2003) · Urology · doi:10.1016/s0090-4295(03)00754-4 · Cited by 130
Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression
Johnson, E. M., Whyte, E. M., Mulsant, B. H., Pollock, B. G., Weber, E., Begley, A. E., & Reynolds, C. F. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000204328.50105.b3 · Cited by 130
Coupland, C. A. C., Hill, T., Morriss, R. K., Moore, M. V., Arthur, A. J., & Hippisley‐Cox, J. (2016) · BMJ · doi:10.1136/bmj.i1350 · Cited by 130
Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults
Deuschle, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835a4206 · Cited by 130
Degner, D., Grohmann, R., Kropp, S., Rüther, E., Bender, S., Engel, R. R., & Schmidt, L. G. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-815509 · Cited by 128
Sexual Side-Effects of Contemporary Antidepressants: Review
Schweitzer, I., Maguire, K. P., & Ng, C. H. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903107575 · Cited by 128
Dara, L., Liu, Z., & Kaplowitz, N. (2016) · Liver International · doi:10.1111/liv.12988 · Cited by 127
von Wolff, A., Hölzel, L. P., Westphal, A., Härter, M. C., & Kriston, L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.007 · Cited by 123
Eom, C.-S., Lee, H.-K., Ye, S., Park, S. M., & Cho, K.-H. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1554 · Cited by 123
Pacher, P., Ungvari, Z. I., Nánási, P. P., Fürst, S., & Kecskeméti, V. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220330184544 · Cited by 121
Madhusoodanan, S., Alexeenko, L., Sanders, R., & Brenner, R. (2010) · Annals of Clinical Psychiatry · doi:10.1177/104012371002200303 · Cited by 121
Eberhard‐Gran, M., Eskild, A., & Opjordsmoen, S. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00002 · Cited by 119
Cardiovascular Profile of Duloxetine, a Dual Reuptake Inhibitor of Serotonin and Norepinephrine
Thase, M. E., Trân, P. V., Wiltse, C. G., Pangallo, B. A., Mallinckrodt, C. H., & Detke, M. J. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155815.44338.95 · Cited by 118
Suicidal antidepressant overdoses: A comparative analysis by antidepressant type
White, N. C., Litovitz, T., & Clancy, C. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03161207 · Cited by 117
Hudson, J. I., Wohlreich, M. M., Kajdasz, D. K., Mallinckrodt, C. H., Watkin, J. G., & Martynov, O. V. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.696 · Cited by 116
Targownik, L. E., Bolton, J. M., Metge, C. J., Leung, S., & Sareen, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.128 · Cited by 115
de la Torre, B. R., Dreher, J., Malevany, I., Bagli, M., Kolbinger, M., Omran, H., Lüderitz, B., & Rao, M. L. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200108000-00019 · Cited by 113
Selective Serotonin Reuptake Inhibitors and Other Antidepressants and Risk of Fracture
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2008) · Calcified Tissue International · doi:10.1007/s00223-007-9099-9 · Cited by 111
O’Regan, C., Kenny, R. A., Cronin, H., Finucane, C., & Kearney, P. M. (2014) · Psychological Medicine · doi:10.1017/s0033291714001767 · Cited by 110
Sexual Dysfunction in Major Depression
Williams, K., & Reynolds, M. F. (2006) · CNS Spectrums · doi:10.1017/s1092852900026729 · Cited by 107
Gill, H. S., DeVane, C. L., & Risch, S. C. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00007 · Cited by 107
Growth-Inhibitory Effects of Serotonin Uptake Inhibitors on Human Prostate Carcinoma Cell Lines
Abdul, M., Logothetis, C. J., & Hoosein, N. M. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67288-4 · Cited by 103
A review of the management of antidepressant discontinuation symptoms
Wilson, E., & Lader, M. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612334 · Cited by 103
Braun, C., Bschor, T., Franklin, J., & Baethge, C. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442293 · Cited by 103
Drug-Induced Urinary Incontinence
Tsakiris, P., Oelke, M., & Michel, M. C. (2008) · Drugs & Aging · doi:10.2165/00002512-200825070-00001 · Cited by 99
Short-Term Use of Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Bleeding
Wang, Y., Chen, Y., Tsai, C.-F., Li, S., Luo, J., Wang, S., Tang, C., Liu, C., Lin, H., Lee, F., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12111467 · Cited by 98
Shin, D., Oh, Y. H., Eom, C.-S., & Park, S. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7251-9 · Cited by 98
Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome
Ewing, G., Tatarchuk, Y., Appleby, D. H., Schwartz, N., & Kim, D. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0233-3 · Cited by 97
Maternal use of bupropion and risk for congenital heart defects
Alwan, S. S., Reefhuis, J., Botto, L. D., Rasmussen, S. A., Correa, A., & Friedman, J. M. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.015 · Cited by 96
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Self-citationOffidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Self-citationAntidepressant dose, age, and the risk of deliberate self-harm
Miller, M., Swanson, S. A., Azrael, D., Pate, V., & Stürmer, T. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1053 · Cited by 92
Persistent Sexual Side Effects after SSRI Discontinuation
Csoka, A. B., & Shipko, S. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091777 · Cited by 92
Antidepressant-induced sexual dysfunction in men
Segraves, R. T., & Balon, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.003 · Cited by 90
Costagliola, C., Parmeggiani, F., & Sebastiani, A. (2004) · CNS Drugs · doi:10.2165/00023210-200418080-00001 · Cited by 89
Pharmacotherapy of Mood Disorders
Thase, M. E., & Denko, T. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095301 · Cited by 88
Factors predicting adherence to antidepressant treatment
Hung, C.-I. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000086 · Cited by 88
A systematic review of agomelatine-induced liver injury
Freiesleben, S. D., & Furczyk, K. (2015) · Journal of Molecular Psychiatry · doi:10.1186/s40303-015-0011-7 · Cited by 87
Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme
Letmaier, M., Painold, A., Holl, A. K., Vergin, H., Engel, R., Konstantinidis, A., Kasper, S., & Grohmann, R. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001192 · Cited by 87
Mixed Depression: Clinical Features and Predictors of Its Onset Associated with Antidepressant Use
Sani, G., Napoletano, F., Vöhringer, P. A., Sullivan, M. C., Simonetti, A., Koukopoulos, A., Danese, E., Girardi, P., & Ghaemi, S. N. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000358808 · Cited by 84
Hedenmalm, K., Güzey, C., Dahl, M., Yue, Q., & Spigset, O. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203200.96205.34 · Cited by 84
Bupropion and Restless Legs Syndrome: A Randomized Controlled Trial
Bayard, M. M., Bailey, B. A., Acharya, D., Ambreen, F., Duggal, S., Kaur, T., Rahman, Z., Roller, K., & Tudiver, F. G. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.04.100173 · Cited by 83
SSRIs and gastrointestinal bleeding
Paton, C., & Ferrier, I. N. (2005) · BMJ · doi:10.1136/bmj.331.7516.529 · Cited by 81
Ecological Studies of Antidepressant Treatment and Suicidal Risks
Baldessarini, R. J., Tondo, L., Strombom, I., Dominguez, S., FAWCETT, J. A., Licinio, J., Oquendo, M. A., Tollefson, G. D., Valuck, R. J., & Tohen, M. F. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701551102 · Cited by 81
Reasons for Antidepressant Nonadherence Among Veterans Treated in Primary Care Clinics
Fortney, J. C., Pyne, J. M., Edlund, M. J., Stecker, T., Mittal, D., Robinson, D. E., & Henderson, K. L. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05528blu · Cited by 80
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., & Kennedy, S. H. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.4.523 · Cited by 80
Adverse reactions of antidepressants in elderly patients.
Pollock, B. G. (1999) · PubMed · Cited by 79
Antidepressant use and new‐onset diabetes: a systematic review and meta‐analysis
Bhattacharjee, S., Bhattacharya, R., Kelley, G. A., & Sambamoorthi, U. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2393 · Cited by 79
Idiosyncratic drug-induced liver injury: an update on the 2007 overview
Hussaini, S. H., & Farrington, E. A. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.828032 · Cited by 76
Tribl, G. G., Wetter, T. C., & Schredl, M. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.05.001 · Cited by 76
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Rosenblat, J. D., McIntyre, R. S., Alves, G. S., Fountoulakis, K. Ν., & Carvalho, A. F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630175044 · Cited by 76
Self-citationCarcinogenicity studies of fluoxetine hydrochloride in rats and mice.
Bendele, R. A., Adams, E. R., Hoffman, W. P., Gries, C. L., & Morton, D. M. (1992) · PubMed · Cited by 75
Schillevoort, I., van Puijenbroek, E., de Boer, A., Roos, R. A. C., Jansen, P. A. F., & Leufkens, H. G. M. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200203000-00006 · Cited by 75
Extrapyramidal Reactions Associated With Serotonergic Antidepressants
Hawthorne, J. M., & Caley, C. F. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015594812 · Cited by 73
Mika Kivimaki, B., Batty, G. D., Jokela, M. M., Ebmeier, K. P., Vahtera, J., Virtanen, M., Brunner, E. J., Tabák, Á. G., Witte, D. R., Meena Kumari, B., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.008 · Cited by 72
Nefazodone (Serzone) withdrawn because of hepatotoxicity.
Choi, S. (2003) · Europe PMC (PubMed Central) · Cited by 68
Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle–Closure Glaucoma
Chen, H., Lin, C., Lai, S., & Kao, C. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10038 · Cited by 67
Risk Factors for Falls During Treatment of Late-Life Depression
Joo, J. H., Lenze, E. J., Mulsant, B. H., Begley, A. E., Weber, E. M., STACK, J. A., Mazumdar, S., Reynolds, C. F., & Pollock, B. G. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1012 · Cited by 66
Dermatologic Side Effects of Psychotropic Medications
Mitkov, M. V., Trowbridge, R. M., Lockshin, B., & Caplan, J. P. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.07.003 · Cited by 66
Efficacy and safety of antidepressant drug treatment in children and adolescents
Henry, A., Kisicki, M. D., & Varley, C. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.150 · Cited by 64
A review of the adverse effects and safety of noradrenergic antidepressants
Whiskey, E., & Taylor, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113492027 · Cited by 64
Risk of syncope in the elderly and consumption of drugs: A case-control study
Cherin, P., Colvez, A., de Périère, D. D., & Séréni, D. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00385-x · Cited by 64
New insights on the antidepressant discontinuation syndrome
Harvey, B. H., & Slabbert, F. N. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2429 · Cited by 63
Meeker, A. S., Herink, M. C., Haxby, D. G., & Hartung, D. M. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0001-y · Cited by 63
Cosgrove, L., Shi, L., Creasey, D. E., Anaya, M., Myers, J. A., & Huybrechts, K. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018210 · Cited by 63
The status of sleep abnormalities as a diagnostic test for major depressive disorder
Arfken, C. L., Joseph, A., Sandhu, G., Roehrs, T., Douglass, A. B., & Boutros, N. N. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.12.007 · Cited by 62
Fava, G. A., Guidi, J., Rafanelli, C., & Sonino, N. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000366041 · Cited by 62
Self-citationCarvalho, A. F., Hyphantis, T. N., Sales, P. M. G., Soeiro‐de‐Souza, M. G., Macêdo, D. S., Cha, D. S., McIntyre, R. S., & Pavlidis, N. A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.009 · Cited by 61
Self-citationBellantuono, C., Vargas, M., Mandarelli, G., Nardi, B., & Martini, M. G. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2473 · Cited by 61
Citrome, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.042 · Cited by 60
Major Depression, Antidepressant Medication and the Risk of Obesity
Patten, S. B., Williams, J. V. A., Lavorato, D. H., Brown, L. C., McLaren, L., & Eliasziw, M. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209349 · Cited by 59
Antidepressant-Induced Sweating
Marcy, T. R., & Britton, M. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e564 · Cited by 59
Bruising Associated with the Use of Fluoxetine
Pai, V. B., & Kelly, M. W. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000716 · Cited by 58
Yau, W., Chan, M., Wing, Y. K., Lam, H., Lin, W., Lam, S., & Lee, C. (2014) · Brain and Behavior · doi:10.1002/brb3.224 · Cited by 57
The cardiovascular safety profile of escitalopram
Thase, M. E., Larsen, K. G., Reines, E. H., & Kennedy, S. H. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.011 · Cited by 56
Mood and Neuropsychological Changes in Women With Midlife Depression Treated With Escitalopram
Wroolie, T. E., Williams, K. E., Keller, J., Zappert, L. N., Shelton, S. D., Kenna, H. A., Reynolds, M. F., & Rasgon, N. L. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000227699.26375.f8 · Cited by 56
Psychiatric medications: Adverse cutaneous drug reactions
Bliss, S. A., & Warnock, J. K. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.11.014 · Cited by 55
Rittenhouse, P. A., Levy, A. D., Li, Q., Bethea, C. L., & de Kar, L. D. V. (1993) · Endocrinology · doi:10.1210/endo.133.2.8344205 · Cited by 55
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. Ν., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0259-6 · Cited by 54
Newer antidepressants: a comparison of tolerability in general practice.
Mackay, F. R., Dunn, N. R., Martin, R. M., Pearce, G. L., Freemantle, S. N., & Mann, R. D. (1999) · Europe PMC (PubMed Central) · Cited by 53
Cheng, Y.-L., Hu, H., Lin, X., Luo, J., Peng, Y., Hou, M., Lin, H., & Lee, F. (2015) · Medicine · doi:10.1097/md.0000000000002022 · Cited by 53
Narayan, V., & Haddad, P. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359094 · Cited by 52
Reis, M., & Källén, B. A. J. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002166 · Cited by 51
Incidence and predictors of activation syndrome induced by antidepressants
Harada, T., Sakamoto, K., & Ishigooka, J. (2008) · Depression and Anxiety · doi:10.1002/da.20438 · Cited by 50
Instruments to measure sexual dysfunction in community and psychiatric populations
Rizvi, S. J., Yeung, N. W., & Kennedy, S. H. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.05.009 · Cited by 49
Survey of Treatment Practices for Sexual Dysfunction(s) Associated with Anti-Depressants
Balon, R., & Segraves, R. T. (2008) · Journal of Sex & Marital Therapy · doi:10.1080/00926230802096390 · Cited by 48
Serotonergic Antidepressants and Urinary Incontinence
Votolato, N. A., Stern, S. L., & Caputo, R. M. (2000) · International Urogynecology Journal · doi:10.1007/s001920070009 · Cited by 48
Selective Serotonin Reuptake Inhibitors and the Risk of Cataracts
Etminan, M., Mikelberg, F. S., & Brophy, J. M. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.11.042 · Cited by 45
The FDA Warning on Antidepressants and Suicidality — Why the Controversy?
Stone, M. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1411138 · Cited by 45
Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362317 · Cited by 44
Cardiovascular Effects of Selective Serotonin Reuptake Inhibitors and Other Novel Antidepressants
Khawaja, I. S., & Feinstein, R. E. (2003) · Heart Disease · doi:10.1097/01.hdx.0000061695.97215.64 · Cited by 43
Levomilnacipran for the treatment of major depressive disorder: a review
Asnis, G. M., & Henderson, M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s54710 · Cited by 42
Boucher, N., Koren, G., & Beaulac-Baillargeon, L. (2009) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181a58fb4 · Cited by 42
Research works printed but not linked: 1
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Self-citationMcCarron, R. M., Shapiro, B., Rawles, J., & Luo, J. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202105180 · Cited by 492
Buckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D., Fearon, P., & Pilling, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.07.005 · Cited by 398
Depression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
Self-citationKietaibl, S., Ahmed, A., Afshari, A., Albaladejo, P., Aldecoa, C., Barauskas, G., De Robertis, E., Faraoni, D., Filipescu, D. C., Fries, D., et al. (2023) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001803 · Cited by 345
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.